C21 · Pharmaceuticals · Global
Medicines in clinical development
Global: 12,900 in 2025.
- 12,900 Latest · Global · 2025
- Annual Release cadence
- 1 Record · 1 region · 2025
Verified 15 Sep 2026 · 1 publisher · Next period 2026
The figure
One published observation so far. A chart follows as soon as a second period is published.
Medicines in clinical development
Global, 2025
Every record
1 record · 1 region · 2025. Each period links to its record: the value, its source evidence and original document.
Download this data
Every file carries its provenance: the CSV has a source column per row, and the chart images print the publisher, the licence and this page's address under the drawing. Source: IFPMA. Licence: CC BY 4.0.
Use and publication rights
- View, cite and link: free
Quote any number, cite this page or a single record, and link to it anywhere.
- Copy, chart and republish: free with attribution
The data is published under CC BY 4.0, commercial use included. Credit StatOrigin and the original publisher (IFPMA); the chart files already carry that line.
- The source documents: the publisher's terms
Figures are facts read from the publishers' own documents. The documents themselves, their text and design, stay under each publisher's terms; follow the source links for those.
How this measure is built
- Definition
- Total number of medicines actively undergoing clinical development.
- Measure
- One slice of Medicines in clinical development ( form: count ) . Total number of drug candidates actively evaluated in clinical trials. Region and period are columns on every record, not slices.
- Limitations
- Values are shown as published; StatOrigin does not revise, fill gaps or convert currencies.
- Verification
- Each value, unit, period and place was checked against its source evidence before publication. See the methodology and the corrections process.
Sources · 1 document
| Document | Publisher | Published | Data points |
|---|---|---|---|
| Enabling innovation: The R&D ecosystem for medicines and vaccines | IFPMA | — | 1 |
Other slices of medicines in clinical development
- Share of global biopharmaceutical pipeline 2 biopharmaceutical
- Share of clinical development medicines dedicated to non-communicable diseases 1 non communicable diseases
- Share of global biopharmaceutical pipeline (snapshot) 1 biopharmaceutical
Frequently asked questions
What is the latest medicines in clinical development?
Global: 12,900 in 2025.
Where does this data come from?
From 1 document published by IFPMA. Every figure on this page links to its record, which preserves the original source evidence.
How often is it updated?
Annual. The newest published period is 2025; the next release should cover 2026. A new figure appears here once the publisher releases it and it passes verification.
Can I use this data?
Yes. StatOrigin publishes it under CC BY 4.0: you may copy, chart and republish it, including commercially, with attribution to StatOrigin and to the original publisher.
Cite this page
Cite the page as a data set, or open any record to cite one figure: each record carries APA, MLA, Chicago and BibTeX forms that credit the original publisher.
StatOrigin. (2026). Medicines in clinical development [Data set]. Retrieved October 28, 2026, from https://statorigin.org/indicators/medicines-in-clinical-development
"Medicines in clinical development." StatOrigin, 2026, https://statorigin.org/indicators/medicines-in-clinical-development. Accessed 28 Oct. 2026.
StatOrigin. "Medicines in clinical development." Data set, 2026. Accessed October 28, 2026. https://statorigin.org/indicators/medicines-in-clinical-development.
@misc{statorigin_medicines_in_clinical_development_2026, title = {Medicines in clinical development}, author = {{StatOrigin}}, year = {2026}, url = {https://statorigin.org/indicators/medicines-in-clinical-development}, note = {Data set. Accessed 2026-10-28} }